ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 190 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q3 2023. The put-call ratio across all filers is 0.86 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $456 | -18.7% | 83,700 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $561 | -73.8% | 83,700 | -65.6% | 0.00% | -33.3% |
| Q1 2023 | $2,145 | +247.1% | 243,000 | +200.0% | 0.00% | 0.0% |
| Q4 2022 | $618 | -99.9% | 81,000 | -16.1% | 0.00% | 0.0% |
| Q3 2022 | $687,000 | -9.5% | 96,500 | +2.8% | 0.00% | 0.0% |
| Q2 2022 | $759,000 | -15.8% | 93,900 | +319.6% | 0.00% | 0.0% |
| Q1 2021 | $901,000 | +1.5% | 22,380 | +49.0% | 0.00% | 0.0% |
| Q4 2020 | $888,000 | -1.0% | 15,019 | -18.6% | 0.00% | -25.0% |
| Q3 2020 | $897,000 | +41.9% | 18,448 | +41.1% | 0.00% | +33.3% |
| Q2 2020 | $632,000 | – | 13,073 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Eagle Health Investments LP | 1,014,860 | $14,086,000 | 3.47% |
| Triatomic Management LP | 297,048 | $4,123,000 | 3.35% |
| Diametric Capital, LP | 265,000 | $3,678,000 | 2.03% |
| Matrix Capital Management Company, LP | 11,572,590 | $160,628,000 | 1.93% |
| VIKING GLOBAL INVESTORS LP | 29,993,708 | $416,313,000 | 1.68% |
| TIGER MANAGEMENT L.L.C. | 589,311 | $8,180,000 | 1.35% |
| Aristotle Atlantic Partners, LLC | 759,412 | $10,541,000 | 0.65% |
| Casdin Capital, LLC | 1,000,000 | $13,880,000 | 0.62% |
| Pier Capital, LLC | 339,541 | $4,713,000 | 0.60% |
| Leeward Financial Partners, LLC | 68,504 | $951,000 | 0.59% |